Tanner Pharma

Company Deals

Ascentage Pharma Launches Olverembatinib Named Patient Program with Tanner Pharma

Fineline Cube Jul 26, 2022

China-based Ascentage Pharma (HKG: 6855) announced the launch of a Named Patient Program (NPP) for...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod